John L Lamattina is Director of Immunome Inc.. Currently has a direct ownership of 66,953 shares of IMNM, which is worth approximately $744,517. The most recent transaction as insider was on Jan 15, 2023, when has been sold 15,125 shares (Common Stock) at a price of $4.0 per share, resulting in proceeds of $60,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 67K
0% 3M change
0% 12M change
Total Value Held $744,517

JOHN L LAMATTINA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 15 2023
BUY
Grant, award, or other acquisition
$60,500 $4.0 p/Share
15,125 Added 18.43%
66,953 Common Stock
May 24 2021
BUY
Open market or private purchase
$100,694 $18.51 p/Share
5,440 Added 9.5%
51,828 Common Stock
Oct 06 2020
BUY
Conversion of derivative security
-
46,388 Added 50.0%
46,388 Common Stock

Also insider at

LGND
LIGAND PHARMACEUTICALS INC Healthcare
JLL

John L Lamattina

Director
Emeryville, CA

Track Institutional and Insider Activities on IMNM

Follow Immunome Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMNM shares.

Notify only if

Insider Trading

Get notified when an Immunome Inc. insider buys or sells IMNM shares.

Notify only if

News

Receive news related to Immunome Inc.

Track Activities on IMNM